[Assessment of the informative value of neuron-specific enolase determined by the immunoenzyme method].
The diagnostic informative value of measurements of neuron-specific enolase (NSE) in health, pulmonary cancer (including small-cell one), 8 different diseases, and pregnant patients with gestation periods from 5 to 33 weeks was assessed. Comparison of the results in each of these 10 groups with the results in health controls did not reveal any appreciable differences for any of the groups or between the tested groups. The authors consider that NSE measurements cannot be recommended for use at other than cancer institutions.
Toropova
N E
NE
Dorofeeva
E A
EA
Dvorianinova
S P
SP
Vasneva
Zh P
ZhP
D014408:Biomarkers, Tumor; D001943:Breast Neoplasms / Q000175:diagnosis; D018288:Carcinoma, Small Cell / Q000175:diagnosis; D004796:Clinical Enzyme Tests; D003937:Diagnosis, Differential; D005069:Evaluation Studies as Topic; D005260:Female; D005833:Genital Neoplasms, Female / Q000175:diagnosis; D006801:Humans; D007124:Immunoenzyme Techniques; D008175:Lung Neoplasms / Q000175:diagnosis; D008297:Male; D008654:Mesothelioma / Q000175:diagnosis; D010190:Pancreatic Neoplasms / Q000175:diagnosis; D010751:Phosphopyruvate Hydratase / Q000097:blood*; D010997:Pleural Neoplasms / Q000175:diagnosis; D011247:Pregnancy
D014408:Biomarkers, Tumor; D010751:Phosphopyruvate Hydratase
Otsenka informativnosti neĭronspetsificheskoĭ enolazy, opredeliaemoĭ immunofermentnym metodom.